牛叉诊股

[{"date":"2026.07.16","stock":"3.58","trade":"0.36","ind":"-1.97"},{"date":"2026.07.15","stock":"5.39","trade":"2.67","ind":"-0.97"},{"date":"2026.07.14","stock":"0.65","trade":"2.74","ind":"2.77"},{"date":"2026.07.13","stock":"-0.11","trade":"-1.36","ind":"-3.48"},{"date":"2026.07.10","stock":"2.22","trade":"3.33","ind":"-2.29"},{"date":"2026.07.09","stock":"-0.11","trade":"0.10","ind":"3.07"},{"date":"2026.07.08","stock":"-0.99","trade":"-1.54","ind":"-1.87"},{"date":"2026.07.07","stock":"-5.98","trade":"-4.28","ind":"-1.24"},{"date":"2026.07.06","stock":"4.41","trade":"1.41","ind":"-1.16"},{"date":"2026.07.03","stock":"1.42","trade":"1.88","ind":"0.64"},{"date":"2026.07.02","stock":"0.77","trade":"-0.24","ind":"-3.85"},{"date":"2026.07.01","stock":"3.41","trade":"4.33","ind":"-0.53"},{"date":"2026.06.30","stock":"-4.14","trade":"-0.54","ind":"2.48"},{"date":"2026.06.29","stock":"3.50","trade":"7.43","ind":"0.19"},{"date":"2026.06.26","stock":"-5.14","trade":"-3.87","ind":"-3.44"},{"date":"2026.06.25","stock":"0.32","trade":"-1.00","ind":"1.82"},{"date":"2026.06.24","stock":"-4.61","trade":"-1.03","ind":"1.24"},{"date":"2026.06.23","stock":"0.31","trade":"2.96","ind":"-3.17"},{"date":"2026.06.22","stock":"-9.99","trade":"-0.76","ind":"2.13"},{"date":"2026.06.18","stock":"-5.01","trade":"1.76","ind":"0.94"},{"date":"2026.06.17","stock":"-3.07","trade":"-0.52","ind":"1.31"}]

派林生物,深证成指,生物制品指数

压力支撑

该股压力位为9.83元，支撑位为9.51元。

[{"text":"\u538b\u529b\u4f4d","value":"9.83","date":1784131200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"9.51","date":1784131200,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前正处于反弹阶段，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：6.0资金面打败了80%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力筹码较分散，呈低度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

生物制品行业，近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。

更新时间：07月16日 20:30

机构今日流向(万元)	1325.90	机构5日流向(万元)	5506.55
机构10日流向(万元)	3750.19	机构20日流向(万元)	5375.27

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量减少6685.41万股，其中基金数没有增加，主力净减仓115家，请投资者中长期谨慎为宜。

截止2025-12-31，共105家主力机构（基金98家，一般法人6家，阳光私募1家），持仓量总计45298.77万股，占流通A股48.15%
其中，基金持仓与2025-06-30相比：
增仓：19家，增持 128.91万股
减仓：19家，减持 453.30万股
新出现在主力名单中：35家，持有2004.96万股
从主力名单中消失：150家，原持有8355.98万股

消息面诊股

诊断结果：4.5消息面打败了8%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

重大利空	业绩预告	业绩大幅下降	2026-07-15
一般消息	重大事项	公司股东股份解押	2026-07-15
一般消息	资产重组	公司股权转让	2026-06-18
一般消息	股东大会	临时股东大会	2026-06-13
一般消息	募资投向		2026-06-03
一般消息	重大事项	公司股东股份解押	2026-05-21
一般消息	分红转增	不分配不转增	2026-04-29
一般消息	高管变动	取消监事会	2025-12-22
一般消息	分红转增	不分配不转增	2025-08-22

一年消息统计

	所有消息	重大消息	非重大消息
利好	0条	0条	0条
利空	1条	1条	0条

行业面诊股

诊断结果：7.7行业面打败了96%的股票生物制品行业最新资金流向

近10日来该行业走势明显向上，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势明显向上，跑赢大盘。

[{"date":"2026.07.16","price":"-1.97","value":"0.36"},{"date":"2026.07.15","price":"-0.97","value":"2.67"},{"date":"2026.07.14","price":"2.77","value":"2.74"},{"date":"2026.07.13","price":"-3.48","value":"-1.36"},{"date":"2026.07.10","price":"-2.29","value":"3.33"},{"date":"2026.07.09","price":"3.07","value":"0.10"},{"date":"2026.07.08","price":"-1.87","value":"-1.54"},{"date":"2026.07.07","price":"-1.24","value":"-4.28"},{"date":"2026.07.06","price":"-1.16","value":"1.41"},{"date":"2026.07.03","price":"0.64","value":"1.88"},{"date":"2026.07.02","price":"-3.85","value":"-0.24"},{"date":"2026.07.01","price":"-0.53","value":"4.33"},{"date":"2026.06.30","price":"2.48","value":"-0.54"},{"date":"2026.06.29","price":"0.19","value":"7.43"},{"date":"2026.06.26","price":"-3.44","value":"-3.87"},{"date":"2026.06.25","price":"1.82","value":"-1.00"},{"date":"2026.06.24","price":"1.24","value":"-1.03"},{"date":"2026.06.23","price":"-3.17","value":"2.96"},{"date":"2026.06.22","price":"2.13","value":"-0.76"},{"date":"2026.06.18","price":"0.94","value":"1.76"},{"date":"2026.06.17","price":"1.31","value":"-0.52"}]

深证成指,生物制品行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	百普赛斯	39.36%	11.78%	6.5分
2	艾迪药业	34.58%	21.13%	6.9分
3	君实生物	32.83%	8.44%	6.6分
4	三生国健	32.78%	0.00%	5.5分
5	诺唯赞	30.89%	5.39%	6.2分
6	诺诚健华	30.87%	0.38%	5.8分
7	康辰药业	30.60%	18.72%	7.3分
8	昊帆生物	28.81%	6.43%	6.2分
9	甘李药业	28.33%	10.62%	6.6分
10	赛升药业	28.22%	10.00%	5.9分
11	迈威生物	27.33%	11.18%	6.3分
12	义翘神州	26.34%	9.43%	6.5分
13	荣昌生物	25.74%	4.01%	5.9分
14	智翔金泰	24.22%	8.11%	5.8分
15	我武生物	24.11%	12.18%	6.7分
16	四环生物	23.25%	-3.01%	5.6分
17	禾元生物	22.80%	12.94%	6.2分
18	科兴制药	20.14%	7.77%	6.2分
19	-	19.66%	-8.30%	分
20	双成药业	19.27%	10.74%	6.0分
21	长春高新	19.05%	15.25%	5.9分
22	康弘药业	18.98%	7.72%	6.3分
23	沃森生物	17.66%	11.92%	6.8分
24	神州细胞	16.94%	6.98%	6.6分
25	百奥泰	16.80%	7.42%	6.1分
26	通化东宝	16.42%	7.79%	6.9分
27	近岸蛋白	14.71%	7.14%	5.4分
28	-	13.95%	6.41%	分
29	安科生物	13.58%	7.41%	6.9分
30	金迪克	11.90%	8.21%	4.9分
31	百克生物	11.46%	9.49%	6.1分
32	上海莱士	11.37%	15.85%	6.6分
33	康泰生物	11.35%	13.12%	6.4分
34	博晖创新	11.11%	13.38%	5.9分
35	西藏药业	10.97%	9.00%	6.6分
36	特宝生物	10.50%	9.86%	6.7分
37	华兰疫苗	10.31%	10.11%	6.1分
38	优宁维	8.66%	8.45%	5.7分
39	华兰生物	6.47%	8.16%	6.2分
40	康希诺	6.41%	7.78%	5.7分
41	辽宁成大	6.35%	8.25%	6.3分
42	康华生物	6.21%	8.76%	5.9分
43	天坛生物	5.11%	9.65%	5.9分
44	成大生物	4.41%	5.80%	5.6分
45	智飞生物	2.78%	13.98%	6.0分
46	*ST未名	2.54%	24.77%	5.7分
47	博雅生物	2.01%	12.73%	6.1分
48	东宝生物	-0.37%	6.60%	5.8分
49	卫光生物	-0.59%	6.17%	5.5分
50	-	-9.61%	0.27%	分
51	欧林生物	-10.01%	-16.89%	5.0分
52	派林生物	-11.07%	12.20%	6.4分
53	万泽股份	-12.85%	-12.34%	5.1分
54	赛伦生物	-18.94%	-2.32%	4.2分

<上一页 1 2 3 4 5...9 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：6.1基本面打败了57%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，多数机构认为该股长期投资价值较高，投资者可加强关注。

个股深一度

潜在高分红能力：弱（52.5分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：较强，高于行业平均，两项指标的行业排名分别为 31/71 ， 43/71。

[{"date":"2026-03-31","value":"0.28","vol":"-6.01"},{"date":"2025-12-31","value":"5.24","vol":"-12.99"},{"date":"2025-09-30","value":"4.48","vol":"-10.09"},{"date":"2025-06-30","value":"2.98","vol":"-0.66"},{"date":"2025-03-31","value":"1.12","vol":"-0.34"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	0.28	5.24	4.48	2.98	1.12
行业(%)	-6.01	-12.99	-10.09	-0.66	-0.34

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"34.82","vol":"61.43"},{"date":"2025-12-31","value":"41.53","vol":"66.53"},{"date":"2025-09-30","value":"46.32","vol":"67.71"},{"date":"2025-06-30","value":"47.63","vol":"66.67"},{"date":"2025-03-31","value":"48.06","vol":"38.38"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	34.82	41.53	46.32	47.63	48.06
行业(%)	61.43	66.53	67.71	66.67	38.38

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 36/71 ， 43/71。

[{"date":"2026-03-31","value":"-8.47","vol":"297.05"},{"date":"2025-12-31","value":"-0.83","vol":"39.85"},{"date":"2025-09-30","value":"-14.40","vol":"45.81"},{"date":"2025-06-30","value":"-13.18","vol":"6902.14"},{"date":"2025-03-31","value":"-14.00","vol":"6125.11"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	-8.47	-0.83	-14.40	-13.18	-14.00
行业(%)	297.05	39.85	45.81	6902.14	6125.11

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"-74.22","vol":"74.22"},{"date":"2025-12-31","value":"-43.75","vol":"33.79"},{"date":"2025-09-30","value":"-34.19","vol":"45.67"},{"date":"2025-06-30","value":"-27.89","vol":"5.21"},{"date":"2025-03-31","value":"-26.95","vol":"-8.79"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	-74.22	-43.75	-34.19	-27.89	-26.95
行业(%)	74.22	33.79	45.67	5.21	-8.79

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：一般，低于行业平均，两项指标的行业排名分别为 34/71 ， 40/71。

[{"date":"2026-03-31","value":"0.04","vol":"0.06"},{"date":"2025-12-31","value":"0.28","vol":"0.29"},{"date":"2025-09-30","value":"0.17","vol":"0.21"},{"date":"2025-06-30","value":"0.11","vol":"0.13"},{"date":"2025-03-31","value":"0.04","vol":"0.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.04	0.28	0.17	0.11	0.04
行业(次)	0.06	0.29	0.21	0.13	0.06

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.13","vol":"0.29"},{"date":"2025-12-31","value":"1.10","vol":"1.29"},{"date":"2025-09-30","value":"0.59","vol":"0.90"},{"date":"2025-06-30","value":"0.36","vol":"0.55"},{"date":"2025-03-31","value":"0.15","vol":"0.25"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	0.13	1.10	0.59	0.36	0.15
行业(次)	0.29	1.29	0.90	0.55	0.25

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"-50.11","vol":"-78.67"},{"date":"2025-12-31","value":"-11.78","vol":"12.85"},{"date":"2025-09-30","value":"15.23","vol":"0.21"},{"date":"2025-06-30","value":"-12.56","vol":"-1377.65"},{"date":"2025-03-31","value":"-30.92","vol":"-2083.82"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	-50.11	-11.78	15.23	-12.56	-30.92
行业	-78.67	12.85	0.21	-1377.65	-2083.82

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"2.20","vol":"1.74"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"2.50","vol":"1.55"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	2.20	-	2.50	-
行业	0.00	1.74	0.00	1.55	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 24/71 ， 17/71。

[{"date":"2026-03-31","value":"3.37","vol":"6.66"},{"date":"2025-12-31","value":"3.30","vol":"5.80"},{"date":"2025-09-30","value":"2.93","vol":"6.07"},{"date":"2025-06-30","value":"3.67","vol":"6.57"},{"date":"2025-03-31","value":"4.19","vol":"7.73"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	3.37	3.30	2.93	3.67	4.19
行业	6.66	5.80	6.07	6.57	7.73

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"1.59","vol":"5.14"},{"date":"2025-12-31","value":"1.88","vol":"4.43"},{"date":"2025-09-30","value":"1.56","vol":"4.89"},{"date":"2025-06-30","value":"1.87","vol":"5.24"},{"date":"2025-03-31","value":"2.37","vol":"6.33"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	1.59	1.88	1.56	1.87	2.37
行业	5.14	4.43	4.89	5.24	6.33

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 31/71 ， 35/71。

[{"date":"2026-03-31","value":"13.63","vol":"28.78"},{"date":"2025-12-31","value":"14.63","vol":"28.75"},{"date":"2025-09-30","value":"16.25","vol":"28.02"},{"date":"2025-06-30","value":"13.04","vol":"26.19"},{"date":"2025-03-31","value":"12.94","vol":"26.65"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	13.63	14.63	16.25	13.04	12.94
行业(%)	28.78	28.75	28.02	26.19	26.65

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.16","vol":"2.54"},{"date":"2025-12-31","value":"0.17","vol":"1.42"},{"date":"2025-09-30","value":"0.19","vol":"0.58"},{"date":"2025-06-30","value":"0.15","vol":"1.11"},{"date":"2025-03-31","value":"0.15","vol":"0.80"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	0.16	0.17	0.19	0.15	0.15
行业(%)	2.54	1.42	0.58	1.11	0.80

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
东北证券	2026-06-04	增持
华源证券	2026-05-28	买入
国投证券	2026-05-02	买入

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"5.87","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"6.12","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"7.45","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"4.19","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"4.25","blueLineValue":"0.45","type":"YC"}]

[派林生物]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]